← All companies
REGN annual revenue
REGENERON PHARMACEUTICALS, INC.
REGN - CIK 0000872589
Market cap$56.80 B
Rank#292
SEC filings985
REGENERON PHARMACEUTICALS, INC. revenue by year
REGENERON PHARMACEUTICALS, INC. (REGN) reported revenue of $14.34B for fiscal year 2025, as filed in its audited annual report with the SEC.
REGN revenue 2011-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $14.34B | +1.0% |
| FY 2024 | $14.20B | +8.3% |
| FY 2023 | $13.12B | +7.8% |
| FY 2022 | $12.17B | -24.3% |
| FY 2021 | $16.07B | +89.1% |
| FY 2020 | $8.50B | +29.6% |
| FY 2019 | $6.56B | +27.4% |
| FY 2018 | $5.15B | -12.4% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does REGENERON PHARMACEUTICALS, INC. make?
REGENERON PHARMACEUTICALS, INC. (REGN) reported revenue of $14.34B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has REGENERON PHARMACEUTICALS, INC.'s revenue changed over time?
Between fiscal 2011 and fiscal 2025, REGENERON PHARMACEUTICALS, INC.'s revenue grew from $445.82M to $14.34B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.